Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial (ClinicalTrials.gov Identifier: NCT01928771) – Publicado no The Lancet
Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma (Sygma1) (ClinicalTrials.gov Identifier: NCT02149199) Publicado no NEJM
